G

Guangdong Marubi Biotechnology Co Ltd
SSE:603983

Watchlist Manager
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Watchlist
Price: 34.34 CNY 0.67% Market Closed
Market Cap: 13.8B CNY
Have any thoughts about
Guangdong Marubi Biotechnology Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Guangdong Marubi Biotechnology Co Ltd

Revenue
2.6B CNY
Cost of Revenue
-720.6m CNY
Gross Profit
1.9B CNY
Operating Expenses
-1.6B CNY
Operating Income
281.5m CNY
Other Expenses
42.9m CNY
Net Income
324.4m CNY

Income Statement
Guangdong Marubi Biotechnology Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
1 576
N/A
1 606
+2%
1 662
+4%
1 732
+4%
1 801
+4%
1 807
+0%
1 780
-1%
1 727
-3%
1 745
+1%
1 779
+2%
1 825
+3%
1 745
-4%
1 787
+2%
1 766
-1%
1 730
-2%
1 793
+4%
1 732
-3%
1 826
+5%
1 974
+8%
2 124
+8%
2 226
+5%
2 410
+8%
2 518
+4%
2 641
+5%
Gross Profit
Cost of Revenue
(503)
(530)
(549)
(571)
(579)
(599)
(592)
(574)
(596)
(628)
(667)
(669)
(655)
(647)
(606)
(608)
(557)
(594)
(638)
(654)
(665)
(694)
(699)
(721)
Gross Profit
1 073
N/A
1 076
+0%
1 113
+3%
1 161
+4%
1 222
+5%
1 208
-1%
1 188
-2%
1 153
-3%
1 149
0%
1 151
+0%
1 158
+1%
1 076
-7%
1 133
+5%
1 118
-1%
1 124
+1%
1 185
+5%
1 175
-1%
1 232
+5%
1 336
+9%
1 470
+10%
1 560
+6%
1 716
+10%
1 820
+6%
1 921
+6%
Operating Income
Operating Expenses
(621)
(602)
(598)
(582)
(656)
(660)
(650)
(652)
(668)
(698)
(762)
(809)
(890)
(914)
(953)
(955)
(1 013)
(1 053)
(1 147)
(1 258)
(1 371)
(1 492)
(1 569)
(1 639)
Selling, General & Administrative
(619)
(606)
(628)
(614)
(643)
(644)
(628)
(633)
(653)
(680)
(730)
(765)
(856)
(872)
(897)
(903)
(975)
(1 014)
(1 106)
(1 213)
(1 320)
(1 440)
(1 510)
(1 581)
Research & Development
(34)
(34)
(35)
(37)
(45)
(46)
(51)
(52)
(50)
(52)
(51)
(53)
(50)
(52)
(51)
(49)
(53)
(53)
(57)
(60)
(62)
(65)
(69)
(72)
Depreciation & Amortization
(8)
0
0
0
(9)
0
0
0
(8)
0
0
0
(11)
0
0
0
(9)
0
0
0
(7)
0
0
0
Other Operating Expenses
40
39
65
69
40
30
28
33
43
34
19
10
27
10
(5)
(3)
24
14
17
14
19
13
11
14
Operating Income
451
N/A
474
+5%
516
+9%
579
+12%
565
-2%
548
-3%
538
-2%
500
-7%
481
-4%
453
-6%
396
-13%
267
-32%
242
-9%
204
-16%
171
-16%
230
+34%
161
-30%
179
+11%
189
+6%
212
+12%
189
-11%
225
+19%
251
+12%
282
+12%
Pre-Tax Income
Interest Income Expense
33
36
43
55
56
71
92
99
92
86
62
50
54
57
54
58
46
46
43
38
133
127
129
128
Non-Reccuring Items
(0)
0
0
0
(9)
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
(3)
1
1
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
Total Other Income
2
2
1
1
1
(4)
(3)
(5)
(5)
(0)
11
10
11
11
(0)
(0)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
Pre-Tax Income
486
N/A
512
+5%
560
+9%
635
+13%
614
-3%
616
+0%
627
+2%
594
-5%
567
-5%
539
-5%
468
-13%
328
-30%
310
-6%
273
-12%
225
-17%
288
+28%
207
-28%
224
+8%
232
+4%
250
+8%
317
+27%
351
+11%
379
+8%
408
+8%
Net Income
Tax Provision
(74)
(76)
(88)
(99)
(101)
(104)
(101)
(101)
(104)
(96)
(87)
(66)
(68)
(67)
(56)
(68)
(39)
(41)
(47)
(23)
(39)
(41)
(55)
(66)
Income from Continuing Operations
412
436
472
536
513
512
526
494
463
444
381
262
241
206
169
220
167
182
185
227
278
309
323
343
Income to Minority Interest
3
3
5
3
2
0
0
0
1
2
5
6
7
7
7
6
7
5
3
1
(18)
(18)
(18)
(18)
Net Income (Common)
415
N/A
440
+6%
477
+8%
538
+13%
515
-4%
513
0%
527
+3%
494
-6%
464
-6%
446
-4%
385
-14%
268
-30%
248
-8%
213
-14%
176
-18%
226
+28%
174
-23%
187
+8%
188
+0%
228
+21%
259
+14%
291
+12%
305
+5%
324
+6%
EPS (Diluted)
1.15
N/A
1.22
+6%
1.32
+8%
1.36
+3%
1.37
+1%
1.28
-7%
1.33
+4%
1.24
-7%
1.16
-6%
1.11
-4%
0.96
-14%
0.67
-30%
0.62
-7%
0.53
-15%
0.44
-17%
0.57
+30%
0.43
-25%
0.47
+9%
0.47
N/A
0.57
+21%
0.65
+14%
0.73
+12%
0.76
+4%
0.81
+7%

See Also

Discover More